RECOMMENDATIONS

Prophylaxis of infective endocarditis: French recommendations 2002

N Danchin¹, X Duval², C Leport²

¹ Department of Cardiology, Hôpital Européen Georges Pompidou, Paris, France
² Department of Infectious Diseases, Hôpital Bichat, Paris, France

Correspondence to:
Correspondence to:
Professor Nicolas Danchin
Department of Cardiology, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France; nicolas.danchin@egp.ap-hop-paris.fr

Accepted 11 March 2004

Keywords: antibiotic; infective endocarditis; prophylaxis; guidelines

The first 150 words of the full text of this article appear below.

Infective endocarditis is a rare but severe disease, the incidence of which seems to have been stable over the past decades. Streptococci are the most frequent causative organisms. In France, infective endocarditis ranges from 25–30 cases/million inhabitants/year (about 1500 cases/year). The profile of patients presenting with infective endocarditis, though, is changing, with an increased proportion of elderly patients and a decrease of endocarditis due to oral streptococci. Valve surgery for endocarditis is performed in about one patient in two with a perioperative mortality that remains high.

Since 1992, the date of the French consensus conference on the prophylaxis of infective endocarditis, new data have been published, requiring an update of its conclusions. These new data feature the following points:

• Endocarditis remains a severe disease
  
• Bacteraemia causing infective endocarditis is probably more often related to a daily transfer of bacteria from mouth to blood than to occasional oral or dental procedures
  
• . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Patel, A., Burden, D. J, Sandler, J. (2009). Medical disorders and orthodontics. J. Orthod. 36: 1-21 [Abstract] [Full Text]  
• Endorsed by the European Society of Clinical Micro, , Authors/Task Force Members, , Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., Lekakis, J., Lengyel, M., Muller, L., Naber, C. K., Nihoyannopoulos, P., Moritz, A., Zamorano, J. L., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Auricchio, A., Bax, J., Ceconi, C., Dean, V., Filippatos, G., Funck-Brentano, C., Hobbs, R., Kearney, P., McDonagh, T., McGregor, K., Popescu, B. A., Reiner, Z., Sechtem, U., Sirnes, P. A., Tendera, M., Vardas, P., Widimsky, P., Document Reviewers, , Vahanian, A., Aguilar, R., Bongiorni, M. G., Borger, M., Butchart, E., Danchin, N., Delahaye, F., Erbel, R., Franzen, D., Gould, K., Hall, R., Hassager, C., Kjeldsen, K., McManus, R., Miro, J. M., Mokracek, A., Rosenhek, R., San Roman Calvar, J. A., Seferovic, P., Selton-Suty, C., Uva, M. S., Trinchero, R., van Camp, G. (2009). Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 2369-2413 [Full Text]  
• Gopalakrishnan, P. P., Shukla, S. K., Tak, T. (2009). Infective Endocarditis: Rationale for Revised Guidelines for Antibiotic Prophylaxis. Clin Med Res 7: 63-68 [Full Text]  
• Bach, D. S. (2009). Perspectives on the American College of Cardiology/American Heart Association Guidelines for the Prevention of Infective Endocarditis. J Am Coll Cardiol 53: 1852-1854 [Abstract] [Full Text]  
• Daniel, W. G., Flachskampf, F. A. (2009). CHAPTER 22 Infective Endocarditis. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full Text]  
• Prendergast, B D, Harrison, J L, Naber, C K (2008). Commentary on endocarditis prophylaxis: a quaint custom or medical necessity?. Heart 94: 931-934 [Full Text]  
• Duval, X., Leport, C., Danchin, N. (2008). The new American Heart Association guidelines on the prevention of infective endocarditis: culmination of a long process of thought. Heart 94: 715-716 [Full Text]  
• Sommer, R. J., Hijazi, Z. M., Rhodes, J. F. Jr (2008). Pathophysiology of Congenital Heart Disease in the Adult: Part I: Shunt Lesions. Circulation 117: 1090-1099 [Full Text]  
• Bogle, R. G, Ashrafian, H. (2007). The authors reply. Heart 93: 753-754 [Full Text]  
• Moreillon, P., Wilson, W. R., Leclercq, R., Entenza, J. M. (2007). Single-Dose Oral Amoxicillin or Linezolid for Prophylaxis of Experimental Endocarditis Due to Vancomycin-Susceptible and Vancomycin-Resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 51: 1661-1665 [Abstract] [Full Text]  
• Delahaye, F., Wong, J., Mills, P. G (2007). Infective endocarditis: a comparison of international guidelines. Heart 93: 524-527 [Full Text]  
• Prendergast, B D (2006). The changing face of infective endocarditis. Heart 92: 879-885 [Abstract] [Full Text]  
• Singh, S. M., Joyner, C. D., Alter, D. A. (2006). The importance of echocardiography in physicians' support of endocarditis prophylaxis.. Arch Intern Med 166: 549-553 [Abstract] [Full Text]  

eLetters:

Read all eLetters

Evidence based endocarditis prophylaxis – a French call to arms?

James E East, et al.

Online, 31 May 2005 [Full text]